March 04, 2015, Mumbai: Sun Pharma Advanced Research Company Ltd. (SPARC) (Reuters: SPRC.BO, Bloomberg: SPADV IN, NSE: SPARC, BSE: 532872) today announced that the U.S. Food and Drug Administration ...
MASON, Ohio, July 22, 2025 /PRNewswire/ -- Aprecia, the global leader in 3DP (three-dimensional print) technology for commercial-scale pharmaceutical manufacturing, today announced that the U.S. Food ...
New Delhi: Granules India Limited announced that its Levetiracetam Tablets have been ANDA approved. The ANDA approval is for 250 mg, 500 mg, 750 mg, and 1,000 mg equivalent tablets. The medication ...
BALTIMORE, Jan. 16 /PRNewswire/ -- Lupin Pharmaceuticals, Inc. (LPI) announced today that it has received final approval for the Company's Abbreviated New Drug Application (ANDA) for Levetiracetam ...
Qualitest announced that it has received approval from the FDA for its Abbreviated New Drug Application (ANDA) for Levetiracetam Extended-Release Tablets, the generic equivalent of UCB Pharma‘s Keppra ...
The Food and Drug Administration has approved the first 3D printed pill. The medicine, Spritam (levetiracetam), helps to treat epilepsy. Previous levetiracetam tablets did not dissolve easily, but the ...
PO/IV- Adjunct in partial seizures- Initial: 500 mg twice daily on the 1st day, may increase gradually. Max: 3 g/day. Monotherapy for partial seizures with or without secondary generalization- Initial ...
We are pleased to announce the launch of generic levetiracetam film-coated tablets. Levetiracetam is a generic version of Keppra ® (levetiracetam) from UCB Pharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results